Page 15 |
Save page Remove page | Previous | 15 of 38 | Next |
|
small (250x250 max)
medium (500x500 max)
Large (1000x1000 max)
Extra Large
large ( > 500x500)
Full Resolution
All (PDF)
|
This page
All
|
10
Table 1A. Number of Cancers Diagnosed at 15-39 years of Age among Females Contributing to Three data Sources, at 20 Sites with Greatest Reported Incidence
Incidencea
Prevalenceb
MEPsc
Site
Order
Count
%
Order
Count
%
Order
Count2
%
Breast
1
213,115
26.3%
2
38,160
21.6%
3
120
11.5%
Thyroid
2
142,619
17.6%
1
51,821
29.3%
7
39
3.7%
Melanoma of the Skin*
3
80,365
9.9%
5
12,933
7.3%
6
59
5.7%
Lymphomal
4
63,786
7.9%
3
14,421
8.2%
8
28
2.7%
Cervix Uteri
5
60,211
7.4%
4
14,390
8.1%
1
388
37.2%
Colon and Rectum
6
32,732
4.0%
6
6,268
3.5%
9
17f
1.6%
Corpus Uteri
7
26,851
3.3%
10
2,942
1.7%
4
119
11.4%
Ovary
8
25,481
3.1%
9
5,046
2.9%
5
73
7.0%
Leukemias
9
24,832
3.1%
7
5,952
3.4%
14
4
0.4%
Brain
10
22,592
2.8%
8
5,312
3.0%
13
5
0.5%
Kidney and Renal Pelvis
11
14,533
1.8%
11
2,848
1.6%
11g
7
0.7%
Soft Tissue including Heart
12
13,061
1.6%
--
--
--
12
6h
0.6%
Lung and Bronchus
13
11,611
1.4%
13
891
0.5%
14
4
0.4%
Oral Cavity and Pharynx
14
11,222
1.4%
12
1,1971
0.7%
17
3j
0.3%
Bones and Joints
15
6,699
0.8%
--
--
--
10
11
1.1%
Stomach
16
5,843
0.7%
17
630
0.4%
14
4
0.4%
Pancreas
17
4,082
0.5%
18
611
0.3%
--
0
--
Vulva
18
3,841
0.5%
15
729
0.4%
--
--
Urinary Bladder, invasive and in situ
19
3,811
0.5%
16
679
0.4%
18
1
0.1%
Small Intestine
20
2,226
0.28%
--
--
--
--
--
--
Other
--
38,993
4.9%
--
1.6%
--
5k
0.5%
Unspecifiedd
--
--
--
--
1,195
0.7%
2
149
14.3%
Totale
--
805,706
100%
--
173,828
100%
--
1,042
100%
*Non-melanoma skin cancers CDC WONDER (N=4,611) and from WHO (N=3,071) were excluded and categorized as other cancers to be compatible with the MEPs AYA cohort
a Data are from selected statewide and metropolitan area cancer registries, 1999-2016, United States of America, ages 15-39, CDC WONDER
b Data are estimated number of prevalent cases in 2018 within a 5-year period, United States of America, ages 15-39, World Health Organization
c Data are collected from MEPs, 2008-2012, United States of America, ages 15-39
Object Description
| Title | A comparison of three different sources of data in assessing the adolescent and young adults cancer survivors |
| Author | Chen, Irene Jiayao |
| Author email | jiayaoch@usc.edu;jiayaoch@usc.edu |
| Degree | Master of Science |
| Document type | Thesis |
| Degree program | Applied Biostatistics and Epidemiology |
| School | Keck School of Medicine |
| Date defended/completed | 2020-08-07 |
| Date submitted | 2020-08-07 |
| Date approved | 2020-08-08 |
| Restricted until | 2020-08-08 |
| Date published | 2020-08-08 |
| Advisor (committee chair) | Cortessis, Victoria |
| Advisor (committee member) |
Miller, Kimberly Farias, Albert |
| Abstract | Relatively limited data resources are available to study Adolescent and Young Adults (AYA) cancers. We created an AYA cancer survivor cohort by identifying survivors (N=1,142) who were 15 to 39 years of age at the time of their first cancer diagnosis, excluding diagnoses of nonmelanoma skin cancers. We characterized the occurrence of incident cancers in the CDC WONDER, prevalent cancers in the Cancer Today and AYA MEPS according to the absolute number and relative frequency of primary cancers diagnosed at ages 15-39 years of age. We compared the distribution of demographic features and cancer types between the three data resources concerning relative frequency. We found an enormous distortion of the sex ratio of survivors, with female cancer survivors overrepresented. Among females diagnosed in the AYA age range, there was a clear overrepresentation of reproductive cancers, such as cervical, ovarian, and corpus uterus. The numerous limitations of MEPS AYA cohort data, lack of representativeness, inaccuracies in the diagnostic data, and readily anticipated based on methodology, emphasize the need for a nationally representative data resource of AYA cancers. |
| Keyword | adolescent and young adult cancers; diagnostic data; limitations |
| Language | English |
| Part of collection | University of Southern California dissertations and theses |
| Publisher (of the original version) | University of Southern California |
| Place of publication (of the original version) | Los Angeles, California |
| Publisher (of the digital version) | University of Southern California. Libraries |
| Provenance | Electronically uploaded by the author |
| Type | texts |
| Legacy record ID | usctheses-m |
| Contributing entity | University of Southern California |
| Rights | Chen, Irene Jiayao |
| Physical access | The author retains rights to his/her dissertation, thesis or other graduate work according to U.S. copyright law. Electronic access is being provided by the USC Libraries in agreement with the author, as the original true and official version of the work, but does not grant the reader permission to use the work if the desired use is covered by copyright. It is the author, as rights holder, who must provide use permission if such use is covered by copyright. The original signature page accompanying the original submission of the work to the USC Libraries is retained by the USC Libraries and a copy of it may be obtained by authorized requesters contacting the repository e-mail address given. |
| Repository name | University of Southern California Digital Library |
| Repository address | USC Digital Library, University of Southern California, University Park Campus MC 7002, 106 University Village, Los Angeles, California 90089-7002, USA |
| Repository email | cisadmin@lib.usc.edu |
| Filename | etd-ChenIreneJ-8901.pdf |
| Archival file | Volume13/etd-ChenIreneJ-8901.pdf |
Description
| Title | Page 15 |
| Full text | 10 Table 1A. Number of Cancers Diagnosed at 15-39 years of Age among Females Contributing to Three data Sources, at 20 Sites with Greatest Reported Incidence Incidencea Prevalenceb MEPsc Site Order Count % Order Count % Order Count2 % Breast 1 213,115 26.3% 2 38,160 21.6% 3 120 11.5% Thyroid 2 142,619 17.6% 1 51,821 29.3% 7 39 3.7% Melanoma of the Skin* 3 80,365 9.9% 5 12,933 7.3% 6 59 5.7% Lymphomal 4 63,786 7.9% 3 14,421 8.2% 8 28 2.7% Cervix Uteri 5 60,211 7.4% 4 14,390 8.1% 1 388 37.2% Colon and Rectum 6 32,732 4.0% 6 6,268 3.5% 9 17f 1.6% Corpus Uteri 7 26,851 3.3% 10 2,942 1.7% 4 119 11.4% Ovary 8 25,481 3.1% 9 5,046 2.9% 5 73 7.0% Leukemias 9 24,832 3.1% 7 5,952 3.4% 14 4 0.4% Brain 10 22,592 2.8% 8 5,312 3.0% 13 5 0.5% Kidney and Renal Pelvis 11 14,533 1.8% 11 2,848 1.6% 11g 7 0.7% Soft Tissue including Heart 12 13,061 1.6% -- -- -- 12 6h 0.6% Lung and Bronchus 13 11,611 1.4% 13 891 0.5% 14 4 0.4% Oral Cavity and Pharynx 14 11,222 1.4% 12 1,1971 0.7% 17 3j 0.3% Bones and Joints 15 6,699 0.8% -- -- -- 10 11 1.1% Stomach 16 5,843 0.7% 17 630 0.4% 14 4 0.4% Pancreas 17 4,082 0.5% 18 611 0.3% -- 0 -- Vulva 18 3,841 0.5% 15 729 0.4% -- -- Urinary Bladder, invasive and in situ 19 3,811 0.5% 16 679 0.4% 18 1 0.1% Small Intestine 20 2,226 0.28% -- -- -- -- -- -- Other -- 38,993 4.9% -- 1.6% -- 5k 0.5% Unspecifiedd -- -- -- -- 1,195 0.7% 2 149 14.3% Totale -- 805,706 100% -- 173,828 100% -- 1,042 100% *Non-melanoma skin cancers CDC WONDER (N=4,611) and from WHO (N=3,071) were excluded and categorized as other cancers to be compatible with the MEPs AYA cohort a Data are from selected statewide and metropolitan area cancer registries, 1999-2016, United States of America, ages 15-39, CDC WONDER b Data are estimated number of prevalent cases in 2018 within a 5-year period, United States of America, ages 15-39, World Health Organization c Data are collected from MEPs, 2008-2012, United States of America, ages 15-39 |
